Literature DB >> 7529965

Insulin-like growth factors: clinical experience in ovarian function.

R P Buyalos1.   

Abstract

Insulin, insulin-like growth factor, and insulin-like growth factor binding proteins have been shown to play major roles in the modulation of both normal and disturbed ovarian physiology. Identification of many of the actions of these peptides was initially characterized using animal models. However, an increasing body of evidence has emerged to clarify their contributions in human reproductive function. It is clear that at various stages of folliculogenesis, local steroid production acts in concert with intraovarian peptides to promote dominant follicle development. This review will discuss the physiologic role(s) of the insulin-insulin-like growth factor-insulin-like growth factor binding protein family in reproductive function and disorders of androgen excess.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529965     DOI: 10.1016/s0002-9343(99)80060-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

Review 1.  Emerging roles for noncoding RNAs in female sex steroids and reproductive disease.

Authors:  Runju Zhang; Victoria Wesevich; Zhaojuan Chen; Dan Zhang; Amanda N Kallen
Journal:  Mol Cell Endocrinol       Date:  2020-07-12       Impact factor: 4.102

Review 2.  Insulin-like growth factors and their binding proteins: Potential relevance to reproductive physiology.

Authors:  Yasunori Yoshimura
Journal:  Reprod Med Biol       Date:  2003-03-25

Review 3.  Use of Growth Hormone in the IVF Treatment of Women With Poor Ovarian Reserve.

Authors:  Roger J Hart
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-24       Impact factor: 5.555

4.  Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome.

Authors:  Chunzhu Li; Chuan Xing; Jiaqi Zhang; Han Zhao; Wenjing Shi; Bing He
Journal:  J Transl Med       Date:  2021-04-13       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.